13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 53 holding rows worth $51,786,091.
- Accession
- 0001381843-23-000002
- Filer
- CIK 1381843
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 53 entries on the cover page, a total value of $51,786,091 stated on the cover page (in dollars after the unit check, H1), rows summing to $51,786,091 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC | 917488108 | COMMON STOCK | 94,000 | $9,449,820 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 100,000 | $7,687,000 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 16,000 | $5,301,440 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 475,000 | $5,286,750 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 150,000 | $5,271,000 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 60,760 | $5,216,246 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 52,000 | $4,845,880 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 65,000 | $4,676,750 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 330,000 | $1,514,700 | dollars as filed | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 230,000 | $993,600 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 379 | $200,938 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 811 | $131,066 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 1,110 | $123,155 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 335 | $122,556 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 220 | $121,152 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 93 | $67,099 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 1,220 | $62,513 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 216 | $62,376 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 309 | $51,204 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 1,061 | $49,092 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 198 | $48,409 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 215 | $44,051 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 414 | $42,845 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 299 | $33,859 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 187 | $33,589 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 791 | $31,260 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 356 | $26,561 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 152 | $22,488 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 186 | $22,216 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 736 | $22,146 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 93 | $22,101 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 440 | $20,161 | dollars as filed | |
| DOXIMITY INC CL A | 26622P107 | Stock | 462 | $15,505 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 292 | $15,453 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 122 | $13,420 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 268 | $13,269 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 52 | $13,098 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 139 | $11,012 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 166 | $9,097 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 344 | $8,882 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,075 | $8,837 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 131 | $7,893 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 475 | $6,797 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 554 | $6,764 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 887 | $6,759 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 226 | $6,690 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 34 | $6,681 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 32 | $6,580 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,300 | $6,448 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 1,069 | $5,666 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 286 | $4,424 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 142 | $4,399 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 158 | $4,394 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-23-000002 | this filing | 2023-02-14 | acceptance time not in the bulk data set |